Departments of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas; and Columbia University, New York, New York.
Corresponding author: Maged Costantine, MD, 301 University Boulevard, Galveston, TX 77555-0587; e-mail: [email protected].
* For a list of other members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric--Fetal Pharmacology Research Units Network, see the Appendix online at http://links.lww.com/AOG/A342.
Supported by grants U10HD047891, U10HD063094, U10HD047892, U10HD047905, and U10HD057753 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Obstetric Pharmacology Research Unit Network (OPRU).
The authors thank the following members who participated in protocol development, oversight, data management, and coordination between clinical research centers: Katrina Burson, RN, Julie Croxford, RN, and Margaret Zimmerle, RN.
The article does not necessarily represent the official views of the NICHD or the National Institutes of Health.
Financial Disclosure The authors did not report any potential conflicts of interest.
